Kingdon Capital Management, L.L.C. Fibrogen Inc Put Options Transaction History

Kingdon Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $3.51 Million - $5.55 Million	-100,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$42.83 - $59.91 $4.28 Million - $5.99 Million	100,000 New	100,000 $5.44 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $1.22 Million - $1.94 Million	-32,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $1.81 Million - $2.17 Million	32,200 New	32,200 $1.96 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $54.4M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.